RECORDATI |
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 51,2 EUR | +0,79% |
|
+0,79% | +4,85% |
Attività
- prodotti farmaceutici e prodotti OTC (67,9%): per il trattamento di delle infezioni virali, delle malattie cardiovascolari, dermatologiche, ginecologiche, ecc.;
- farmaci per le malattie rare (32,1%).
La ripartizione geografica del fatturato è la seguente: Italia (15%), Europa (58,5%), America (17,5%), Australasia (6,2%) e Africa (2,8%).
Numero di dipendenti: 4 455
Vendite per attività
| EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Specialty & Primary Care
65,7
%
| 1 258 | 67,9 % | 1 368 | 65,7 % | +8,75% |
Rare Diseases
34,3
%
| 596 | 32,1 % | 715 | 34,3 % | +19,96% |
Vendite per regione
| EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Europe
56,4
%
| 1 084 | 58,5 % | 1 175 | 56,4 % | +8,37% |
America
19,0
%
| 324 | 17,5 % | 395 | 19,0 % | +22,06% |
Italy
15,2
%
| 277 | 15,0 % | 317 | 15,2 % | +14,36% |
Australasia
6,7
%
| 115 | 6,2 % | 140 | 6,7 % | +21,69% |
Africa
2,7
%
| 53 | 2,9 % | 56 | 2,7 % | +3,96% |
Dirigenti
| Dirigenti | Titolo | Età | Da |
|---|---|---|---|
Robert Koremans
CEO | Chief Executive Officer | 61 | 01/12/21 |
Luigi la Corte
DFI | Director of Finance/CFO | 54 | 01/11/19 |
Andrea Recordati
CHM | Chairman | 52 | 29/04/98 |
Raffaele Sabia
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/17 |
Guido Guidi
BRD | Director/Board Member | 71 | 29/04/20 |
| Investor Relations Contact | 51 | 01/10/20 | |
| General Counsel | - | 01/04/23 | |
Bibianne Bon
LAW | General Counsel | - | 01/04/23 |
| Human Resources Officer | - | 01/01/23 | |
Gabriele Finzi
PRN | Corporate Officer/Principal | - | 01/01/08 |
Amministratori
| Amministratori | Titolo | Età | Da |
|---|---|---|---|
Cathrin Petty
BRD | Director/Board Member | 51 | 12/06/18 |
Giampiero Mazza
BRD | Director/Board Member | 55 | 12/06/18 |
Robert Koremans
CEO | Chief Executive Officer | 61 | 01/12/21 |
Andrea Recordati
CHM | Chairman | 52 | 29/04/98 |
Giorgio de Palma
BRD | Director/Board Member | 49 | 29/04/20 |
Elisa Corghi
BRD | Director/Board Member | 51 | 29/04/22 |
Luigi la Corte
DFI | Director of Finance/CFO | 54 | 01/11/19 |
Kim Stratton
BRD | Director/Board Member | 62 | 16/12/21 |
Guido Guidi
BRD | Director/Board Member | 71 | 29/04/20 |
| Director/Board Member | 60 | 05/02/19 |
Classe di azioni
| Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
|---|---|---|---|---|---|
| Azione A | 1 | 209 125 156 | 97 110 939 ( 46,44 %) | 2 763 813 ( 1,322 %) | 46,44 % |
Partecipazioni
| Nome | Azioni | % | Valorizzazione |
|---|---|---|---|
RECORDATI 1.80% | 3 765 552 | 1.80% | 201 517 130 $ |
PURETECH HEALTH PLC 3.54% | 9 554 140 | 3.54% | 25 840 509 $ |
| 43 103 | 0.71% | 136 420 $ |
Coordinate società
Società del gruppo
| Nome | Categoria e settore |
|---|---|
Herbacos Recordati sro
 Herbacos Recordati sro Household/Personal CareConsumer Non-Durables Part of CVC Advisers Ltd., Herbacos Recordati sro is a Czech company that manufactures and distributes cosmetic products. The company is located in Czechia. |
Household/Personal Care
|
Recordati AG
 Recordati AG Drugstore ChainsRetail Trade Recordati AG engages in the trading in as well as importation and exportation of pharmaceutical, biological, chemical, laboratory, and diagnostic products. It also provides consulting services in the areas of marketing and management, with focus on the pharmaceutical industry. The company was founded on June 8, 2011 and is headquartered in Baar, Switzerland. |
Drugstore Chains
|
Recordati Ilac San ve Tic AS
| |
Recordati BVBA
 Recordati BVBA Medical DistributorsDistribution Services Part of CVC Advisers Ltd., Recordati BV is a trading brokerage in pharmaceutical products and orthopedic articles. The company is located in Belgium. |
Medical Distributors
|
Recordati Ireland Ltd.
 Recordati Ireland Ltd. Pharmaceuticals: MajorHealth Technology Recordati Ireland Ltd. manufactures pharmaceutical products. It offers pharmaceuticals in the therapeutic areas of cardiovascular, antibiotics and antivirals, central nervous system, gastroenterology, dermatological, muscolo-skeletal disorders, genito-urinary system and pain therapy, obstetics and gynaecology and OTC (non-prescription pharmaceuticals). The company was founded in 2002 and is headquartered in Cork, Ireland. |
Pharmaceuticals: Major
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
| Variaz. 1 gen. | Capi. | |
|---|---|---|
| +4,85% | 11,46 Mrd | |
| +32,09% | 693 Mrd | |
| +29,39% | 584 Mrd | |
| -1,34% | 372 Mrd | |
| +20,34% | 332 Mrd | |
| +7,39% | 294 Mrd | |
| +14,25% | 239 Mrd | |
| -3,03% | 211 Mrd | |
| +10,02% | 210 Mrd | |
| +8,49% | 168 Mrd |
- Borsa valori
- Azioni
- Azione REC
- Società Recordati
